Search research articles
Contact Us
Filters
Showing results (191-200 of 211) with videos related to
Page
of 22
Sort By:
The Journal of Biological Chemistry
|
September 15, 1991
Characterization of the cytoplasmic proline-directed protein kinase in proliferative cells and tissues as a heterodimer comprised of p34cdc2 and p58cyclin A
F L Hall, R K Braun, K Mihara, et al.
Therapeutic Drug Monitoring
|
August 1, 1995
Inhibition of trazodone metabolism by thioridazine in humans
N Yasui, K Otani, S Kaneko, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry
|
January 1, 1997
Plasma concentrations of trazodone and m-chlorophenylpiperazine at steady state can be predicted from those after an initial dose of trazodone
K Otani, K Mihara, N Yasui, et al.
Therapeutic Drug Monitoring
|
June 1, 1997
Increased plasma concentrations of bromperidol and its reduced metabolite with levomepromazine, but not with thioridazine
A Suzuki, K Otani, M Ishida, et al.
Psychopharmacology
|
April 16, 1998
Effects of various factors including the CYP2D6 genotype and coadministration of flunitrazepam on the steady-state plasma concentrations of bromperidol and its reduced metabolite
A Suzuki, K Otani, K Mihara, et al.
Journal of Clinical Psychopharmacology
|
August 5, 2000
Therapeutic spectrum of nemonapride and its relationship with plasma concentrations of the drug and prolactin
T Kondo, K Mihara, N Yasui, et al.
Therapeutic Drug Monitoring
|
June 13, 2000
Effect of a genetic polymorphism of CYP1A2 inducibility on the steady state plasma concentrations of haloperidol and reduced haloperidol in Japanese patients with schizophrenia
K Mihara, A Suzuki, T Kondo, et al.
Therapeutic Drug Monitoring
|
April 1, 1997
No effect of the anticholinergic drugs trihexyphenidyl and biperiden on the plasma concentrations of bromperidol and its reduced metabolite
K Otani, M Ishida, N Yasui, et al.
Therapeutic Drug Monitoring
|
June 12, 1999
No pharmacokinetic but pharmacodynamic interactions between cisapride and bromperidol or haloperidol
K Mihara, K Otani, N Yasui, et al.
Biochemical and Biophysical Research Communications
|
February 3, 1998
Cyclin E overexpression responsible for growth of human hepatic tumors with p21WAF1/CIP1/SDI1
T Tsuji, M Miyazaki, K Fushimi, et al.
Page
of 22
Search research articles
Search
Showing results (191-200 of 211) with videos related to
Sort By:
Page
of 22
The Journal of Biological Chemistry
|
September 15, 1991
Characterization of the cytoplasmic proline-directed protein kinase in proliferative cells and tissues as a heterodimer comprised of p34cdc2 and p58cyclin A
F L Hall, R K Braun, K Mihara, et al.
Therapeutic Drug Monitoring
|
August 1, 1995
Inhibition of trazodone metabolism by thioridazine in humans
N Yasui, K Otani, S Kaneko, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry
|
January 1, 1997
Plasma concentrations of trazodone and m-chlorophenylpiperazine at steady state can be predicted from those after an initial dose of trazodone
K Otani, K Mihara, N Yasui, et al.
Therapeutic Drug Monitoring
|
June 1, 1997
Increased plasma concentrations of bromperidol and its reduced metabolite with levomepromazine, but not with thioridazine
A Suzuki, K Otani, M Ishida, et al.
Psychopharmacology
|
April 16, 1998
Effects of various factors including the CYP2D6 genotype and coadministration of flunitrazepam on the steady-state plasma concentrations of bromperidol and its reduced metabolite
A Suzuki, K Otani, K Mihara, et al.
Journal of Clinical Psychopharmacology
|
August 5, 2000
Therapeutic spectrum of nemonapride and its relationship with plasma concentrations of the drug and prolactin
T Kondo, K Mihara, N Yasui, et al.
Therapeutic Drug Monitoring
|
June 13, 2000
Effect of a genetic polymorphism of CYP1A2 inducibility on the steady state plasma concentrations of haloperidol and reduced haloperidol in Japanese patients with schizophrenia
K Mihara, A Suzuki, T Kondo, et al.
Therapeutic Drug Monitoring
|
April 1, 1997
No effect of the anticholinergic drugs trihexyphenidyl and biperiden on the plasma concentrations of bromperidol and its reduced metabolite
K Otani, M Ishida, N Yasui, et al.
Therapeutic Drug Monitoring
|
June 12, 1999
No pharmacokinetic but pharmacodynamic interactions between cisapride and bromperidol or haloperidol
K Mihara, K Otani, N Yasui, et al.
Biochemical and Biophysical Research Communications
|
February 3, 1998
Cyclin E overexpression responsible for growth of human hepatic tumors with p21WAF1/CIP1/SDI1
T Tsuji, M Miyazaki, K Fushimi, et al.
Page
of 22